Join Conscio Group and leading experts from Medicines for Europe on December 10, 2025, at 2:00 PM CET (expected duration up to 80 minutes) for a focused webinar on how to design biosimilar evidence packages that are both streamlined and regulator-ready.
As regulatory expectations evolve, high-quality analytical similarity data, smart PK study design and robust immunogenicity assessment are becoming central to biosimilar approval strategies. This webinar will explore how to make these elements work together in practice – without unnecessary clinical trial burden.
Program highlights:
- Streamlined Biosimilar Development – Regulatory Evolution Backed by Science and Founded in Analytics
Speaker: Mina Grguri, Biosimilar Policy & Science Officer, Medicines for Europe - Integrating Immunogenicity Testing of Biosimilars into PK Study Design: Practical and Analytical Aspects
Speaker: Eliška Kohelová, Deputy Head of Biologics Department, Conscio Group - Opening & market insights
Host: Stephan Holl, CEO, Conscio Group
Take this opportunity to learn from policy, scientific and operational perspectives, and to discuss your questions directly with the speakers during the live Q&A.
Register here to secure your spot. Participation is free!
Want to explore what we discussed in the previous part of this webinar series? Watch the recording of our previous session:
From Analytical Similarity to Clinical Data – Webinar Recording
